CompletedNot applicableNCT03432871

Nicotinamide Riboside and Mitochondrial Biogenesis

Studying Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Cambridge University Hospitals NHS Foundation Trust
Principal Investigator
Patrick Chinnery, Prof.
University of Cambridge
Intervention
Nicotinamide Riboside(dietary_supplement)
Enrollment
13 enrolled
Eligibility
18-70 years · All sexes
Timeline
2017 – 2022

Study locations (1)

Collaborators

University of Cambridge · Medical Research Council Mitochondrial Biology Unit

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03432871 on ClinicalTrials.gov

Other trials for Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy

Additional recruiting or active studies for the same condition.

See all trials for Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy →

← Back to all trials